Patents by Inventor Erik Andries

Erik Andries has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240159661
    Abstract: A system, apparatuses, and methods for assisting a person to improve their health. A person's initial blood sample spectra may be processed to identify components that have been found to reflect the impact of a lifestyle program, without identifying a biomarker in the blood. Each lifestyle program may be associated with its own set of spectra components or channel that indicate the impact of the program on blood spectra. Based on the person's initial blood spectra and the channel associated with each program, a process may generate a recommended set of programs that the person could use to improve their health. This set of programs may be filtered based on a demographic characteristic or characteristics of the person by comparing the set of programs to a ranked list of programs found helpful by people with a similar demographic characteristic.
    Type: Application
    Filed: March 15, 2022
    Publication date: May 16, 2024
    Applicant: COR HEALTH, INC.
    Inventors: Robert G. MESSERSCHMIDT, Erik ANDRIES, Dara ROUHOLIMAN
  • Patent number: 10124210
    Abstract: One or more processors may be configured to receive, via a radio from one or more sensors, one or more streams of sensor values indicating: (1) accelerations of a boxer's arm within a first range of acceleration, measured by a first acceleration sensor, (2) accelerations of a boxer's arm within a second range of acceleration, measured by a second acceleration sensor, and (3) rotation of the boxer's arm measured by a gyroscope sensor. The one or more processors may be configured to determine, based on the received sensor values from the first acceleration sensor, whether a punch landed but not to measure a force or velocity of the punch. The one or more processors may be configured to determine, based on the received sensor values from the second acceleration sensor, at least one of a force or a velocity of the punch but not to detect whether the punch landed.
    Type: Grant
    Filed: March 11, 2016
    Date of Patent: November 13, 2018
    Assignee: KO Luxembourg SARL
    Inventors: Geoffrey Mather, Jeffrey Collins, Mark Ries Robinson, Petras Avizonis, Erik Andries, Johann Ammerlahn, Elena Allen, Paul Loftsgard, Adrey Dolgov
  • Publication number: 20160263458
    Abstract: Sensor systems and methods for quantitative assessment of sports performance are disclosed. In one embodiment, a boxing data server comprises a memory storing predetermined profiles of arm acceleration or rotation over time for one or more types of punches, a radio for communicating with one or more sensors on one or more boxers, and one or more processors. The one or more processors may be configured to receive, via the radio from the one or more sensors, one or more streams of sensor values indicating: (1) accelerations of a boxer's arm within a first range of acceleration, measured by a first acceleration sensor, (2) accelerations of a boxer's arm within a second range of acceleration, measured by a second acceleration sensor, and (3) rotation of the boxer's arm measured by a gyroscope sensor. The one or more processors may be configured to determine, based on the received sensor values from the first acceleration sensor, whether a punch landed but not to measure a force or velocity of the punch.
    Type: Application
    Filed: March 11, 2016
    Publication date: September 15, 2016
    Inventors: Geoffrey Mather, Jeffrey Collins, Mark Ries Robinson, Petras Avizonis, Erik Andries, Johann Ammerlahn, Elena Allen, Paul Loftsgard, Adrey Dolgov
  • Publication number: 20090203588
    Abstract: Genes and gene expression profiles useful for predicting outcome, risk classification, cytogenetics and/or etiology in pediatric acute lymphoblastic leukemia (ALL). OPAL1 is a novel gene associated with outcome and, along with other newly identified genes, represent a novel therapeutic targets.
    Type: Application
    Filed: June 8, 2007
    Publication date: August 13, 2009
    Inventors: Cheryl L. Willman, Paul Helman, Robert Veroff, Monica Mosquera-Caro, George S. Davidson, Shawn B. Martin, Susan R. Atlas, Erik Andries, Huining Kang, Jonathan J. Shuster, Xuefei Wang, Richard C. Harvey, David M. Haaland, Jeffrey W. Potter
  • Publication number: 20060063156
    Abstract: Genes and gene expression profiles useful for predicting outcome, risk classification, cytogenetics and/or etiology in pediatric acute lymphoblastic leukemia (ALL). OPAL1 is a novel gene associated with outcome and, along with other newly identified genes, represent a novel therapeutic targets.
    Type: Application
    Filed: December 5, 2003
    Publication date: March 23, 2006
    Inventors: Cheryl Willman, Paul Helman, Robert Veroff, Monica Mosquera-Caro, George Davidson, Shawn Martin, Susan Atlas, Erik Andries, Huining Kang, Jonathan Shuster, Xuefei Wang, Richard Harvey, David Haaland, Jeffrey Potter